Published • loading... • Updated
'Just the Happiest Kid': Clinical Trial Brightens Future for B.C. Boy - Northern Sentinel
The early trial added two drugs to standard therapy, and all four B.C. children in the study had improved outcomes, doctors said.
- Seven-Year-Old Beckett Tessarolo achieved remission after participating in the North America-wide TINI clinical trial, joining three other B.C. patients with improved outcomes from the study.
- Diagnosed with acute lymphoblastic leukemia at nine months, Beckett's parents Melanie and Geoff chose the TINI trial over standard chemotherapy, saying they "leaned into the advice of the doctors."
- During his eight months of hospital treatment, including an initial 57-day stay, Beckett navigated COVID pandemic-restricted visits; Dr. Rebecca Deyell, clinical instructor in UBC's Department of Pediatrics, described the regimen as "very intensive."
- Now "just the happiest kid," Beckett remains in remission while his family has raised $475,000 for the Leukemia & Lymphoma Society and BC Children's Hospital Foundation.
- Success in the TINI trial prompted the upcoming TINI2 study, which adds a third drug to the regimen, while the new OPTIMISE trial is "designed to match children, adolescents and young adults with high-risk, hard-to-treat cancers to targeted therapies.
Insights by Ground AI
6 Articles
6 Articles
Coverage Details
Total News Sources6
Leaning Left6Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
